Answers are grounded in this paper and cite their sources.
This report of cumulative experiences with the administration of phenylbutazone to 590 patients for a variety of rheumatic diseases provides information of practical importance to those concerned with the use of this drug in clinical practice. Untoward effects were reduced significantly by lower dosages. Specific precautions are suggested.
No takes yet. Share an insight, caveat, or question.
Irving L. Sperling (1959) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: